NCT03220074View on ClinicalTrials.gov

Linezolid for Treatment of Nontuberculous Mycobacterial Diseases

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2022

Conditions
Non-tuberculous Mycobacterial Infections
Interventions
DRUG

Oral Tablet

study drug given and monitored for efficacy and tolerability

Trial Locations (1)

10700

Siriraj Hospital, Bangkoknoi

All Listed Sponsors
collaborator

Siam Pharmaceutical Ltd.

UNKNOWN

lead

Mahidol University

OTHER

NCT03220074 - Linezolid for Treatment of Nontuberculous Mycobacterial Diseases | Biotech Hunter | Biotech Hunter